Triple
T13942276
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | SARS-CoV-2 |
E335284
|
entity |
| Predicate | abbreviation |
P43
|
FINISHED |
| Object | SARS2 |
E335284
|
NE FINISHED |
How this triple was built (2 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: SARS2 | Statement: [SARS-CoV-2, abbreviation, SARS2]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: SARS2 Context triple: [SARS-CoV-2, abbreviation, SARS2]
-
A.
SARS-CoV-2
chosen
SARS-CoV-2 is the novel coronavirus responsible for the global outbreak of the respiratory disease COVID-19.
-
B.
Omicron variant
The Omicron variant is a highly mutated and fast-spreading strain of the SARS-CoV-2 virus that caused major global surges in COVID-19 cases starting in late 2021.
-
C.
Omicron
Omicron is a vowel letter of the Greek alphabet, historically representing a short "o" sound and used today in various scientific and mathematical contexts.
-
D.
BNT162b2
BNT162b2 is an mRNA-based COVID-19 vaccine, co-developed by BioNTech and Pfizer, that became one of the first widely authorized vaccines against SARS-CoV-2.
-
E.
Ad26.COV2.S
Ad26.COV2.S is a single-dose, adenovirus vector-based COVID-19 vaccine developed by Janssen (Johnson & Johnson) to provide protection against SARS-CoV-2 infection.
- F. None of above.
- G. Unsure - the case is ambiguous/there is not enough information to decide.
Provenance (3 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69d81c6081b88190b53e317c3370c8fe |
completed | April 9, 2026, 9:38 p.m. |
| NER | Named-entity recognition | batch_69de2e0f6f3c8190a64058b732b0ac52 |
completed | April 14, 2026, 12:07 p.m. |
| NED1 | Entity disambiguation (via context triple) | batch_69f7ce8bbd8c819084703298ed6d9c87 |
completed | May 3, 2026, 10:39 p.m. |
Created at: April 9, 2026, 10:17 p.m.